Legend Biotech Corporation: Legend Biotech Announces Submiss

The application to the European Medicines Agency is supported by data from the Phase 3 CARTITUDE-4 study, evaluating the safety and efficacy of cilta-cel in the treatment of patients with relapsed

Related Keywords

Japan , United States , China , New Jersey , American , Gewinn Nur , Ying Huang , Hemophagocytic Lymphohistiocytosis , Joanne Choi , Tina Carter , Medicinal Devices Agency , American Society Of Clinical Oncology , Japan Ministry Of Health , Legend Biotech Corporation , Linkedin , European Hematology Association , Janssen Biotech Inc , Janssen Cilag International , European Commission For The Treatment Of Patients , Exchange Commission On , Community Register Of Orphan Medicinal Products , Twitter , American Cancer Society , European Medicines Agency , Drug Administration , Corporate Communications , European Commission , Biotech Corporation , Legend Biotech , Janssen Biotech , American Society , Clinical Oncology , Hematology Association , Hybrid Congress , Release Syndrome , Effector Cell Associated Neurotoxicity Syndrome , Macrophage Activation Syndrome , Risk Evaluation , Mitigation Strategy , Mediated Myelitis , Nerve Palsies , Recurrent Cytopenias , Igg Hypersensitivity Reactions , Use Machines , Prescribing Information , Boxed Warning , Breakthrough Therapy Designation , Orphan Drug Designation , Orphan Medicinal Products , Private Securities Litigation Reform Act , Annual Report , Exchange Commission , Trials Gov , Study Comparing , Versus Pomalidomide , Participants With Relapsed , Lenalidomide Refractory Multiple Myeloma , Accessed May , Multiple Myeloma , Granted Conditional Approval , Refractory Multiple , Accessed March , Ciltacabtagene Autoleucel , Adult Patients , Receives Approval , Community Register , Orphan Medicinal , Today Population Factsheets , Corporate Communications Lead , Senior Manager , Investor Relations , Legend , Biotech , Corporation , Nnounces , Submission , European , Medicines , Agency , Xpanded , Carvykti , Ciltacabtagene , Utoleucel ,